Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takashi Seto

Showing results (41-50 of 242) with videos related to

Pageof 25
Sort By:
Cancer Treatment and Research Communications|October 4, 2021
Phase 1 study of pembrolizumab plus chemotherapy as first-line treatment in Japanese patients with advanced NSCLCTakayasu Kurata, Kazuhiko Nakagawa, Miyako Satouchi, et al.
Japanese Journal of Clinical Oncology|October 13, 2010
Phase I study of topotecan and cisplatin in patients with small cell lung cancerYukito Ichinose, Takashi Seto, Yutaka Nishiwaki, et al.
Journal of Thoracic Disease|May 13, 2020
The impact of immune-inflammation-nutritional parameters on the prognosis of non-small cell lung cancer patients treated with atezolizumabTaichi Matsubara, Shinkichi Takamori, Naoki Haratake, et al.
Frontiers in Oncology|October 31, 2022
Case report: Success of tepotinib therapy in overcoming resistance to osimertinib in a patient with EGFR-mutant lung adenocarcinoma with a potential acquired MET exon 14 skipping mutationShinkichi Takamori, Takashi Seto, Masafumi Yamaguchi, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|May 1, 2023
Quality of life with docetaxel plus cisplatin versus paclitaxel plus carboplatin in patients with completely resected non-small cell lung cancer: quality of life analysis of TORG 0503Ayako Matsuda, Kazue Yamaoka, Hideo Kunitoh, et al.
Japanese Journal of Clinical Oncology|August 6, 2011
LKB1 mutations frequently detected in mucinous bronchioloalveolar carcinomaAtsushi Osoegawa, Takuro Kometani, Kaname Nosaki, et al.
Surgery Today|January 6, 2019
Pneumonectomy after induction chemoradiotherapy for locally advanced non-small cell lung cancer: should curative intent pulmonary resection be avoided?Masafumi Yamaguchi, Shinichiro Shimamatsu, Makoto Edagawa, et al.
Lung Cancer (Amsterdam, Netherlands)|April 3, 2025
Real-world safety and effectiveness of entrectinib in Japanese patients with ROS1 gene fusion-positive, unresectable, advanced/recurrent non-small cell lung cancer: Post-marketing surveillanceTakashi Seto, Sayuri Nakane, Lyu Ji, et al.
JTO Clinical and Research Reports|September 30, 2021
Atezolizumab-Induced Aseptic Meningitis in Patients with NSCLCRyo Toyozawa, Naoki Haratake, Gouji Toyokawa, et al.
Thoracic Cancer|May 30, 2020
Brain cavernous hemangioma mimicking radiation-induced necrosis in a patient with non-small cell lung cancerShinkichi Takamori, Takashi Seto, Mikako Jinnouchi, et al.
Pageof 25

Showing results (41-50 of 242) with videos related to

Sort By:
Pageof 25
Cancer Treatment and Research Communications|October 4, 2021
Phase 1 study of pembrolizumab plus chemotherapy as first-line treatment in Japanese patients with advanced NSCLCTakayasu Kurata, Kazuhiko Nakagawa, Miyako Satouchi, et al.
Japanese Journal of Clinical Oncology|October 13, 2010
Phase I study of topotecan and cisplatin in patients with small cell lung cancerYukito Ichinose, Takashi Seto, Yutaka Nishiwaki, et al.
Journal of Thoracic Disease|May 13, 2020
The impact of immune-inflammation-nutritional parameters on the prognosis of non-small cell lung cancer patients treated with atezolizumabTaichi Matsubara, Shinkichi Takamori, Naoki Haratake, et al.
Frontiers in Oncology|October 31, 2022
Case report: Success of tepotinib therapy in overcoming resistance to osimertinib in a patient with EGFR-mutant lung adenocarcinoma with a potential acquired MET exon 14 skipping mutationShinkichi Takamori, Takashi Seto, Masafumi Yamaguchi, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|May 1, 2023
Quality of life with docetaxel plus cisplatin versus paclitaxel plus carboplatin in patients with completely resected non-small cell lung cancer: quality of life analysis of TORG 0503Ayako Matsuda, Kazue Yamaoka, Hideo Kunitoh, et al.
Japanese Journal of Clinical Oncology|August 6, 2011
LKB1 mutations frequently detected in mucinous bronchioloalveolar carcinomaAtsushi Osoegawa, Takuro Kometani, Kaname Nosaki, et al.
Surgery Today|January 6, 2019
Pneumonectomy after induction chemoradiotherapy for locally advanced non-small cell lung cancer: should curative intent pulmonary resection be avoided?Masafumi Yamaguchi, Shinichiro Shimamatsu, Makoto Edagawa, et al.
Lung Cancer (Amsterdam, Netherlands)|April 3, 2025
Real-world safety and effectiveness of entrectinib in Japanese patients with ROS1 gene fusion-positive, unresectable, advanced/recurrent non-small cell lung cancer: Post-marketing surveillanceTakashi Seto, Sayuri Nakane, Lyu Ji, et al.
JTO Clinical and Research Reports|September 30, 2021
Atezolizumab-Induced Aseptic Meningitis in Patients with NSCLCRyo Toyozawa, Naoki Haratake, Gouji Toyokawa, et al.
Thoracic Cancer|May 30, 2020
Brain cavernous hemangioma mimicking radiation-induced necrosis in a patient with non-small cell lung cancerShinkichi Takamori, Takashi Seto, Mikako Jinnouchi, et al.
Pageof 25